Ascel Bio has previously reported its concern about land-based extension of Ebola into Cote d’Ivoire in the coming weeks. Nimba District, Liberia is associated with the 3rd fastest growing case counts. Nimba is located on Cote d’Ivoire’s northwest border (Montagnes region), with multiple connecting bridges and roadways. There has been a lag in bolstering Nimba District’s medical capacity, according to reports reviewed by Ascel Bio, and the case counts are expanding without signs of improvement. Healthcare workers continue to be infected, with a reported fatality rate of 80%. Cote d’Ivoire is of greater concern than Guinea-Bissau, Senegal, and Mali due to:
Lack of familiarity and experience with a large epidemic of Ebola. Lack of experience is the top indicator for poor outcomes in terms of containment and socio-economic disruption.
Indication of an advancing and uncontained leading edge of the epidemic immediately proximal to the border.
There are 24 million people living in Cote d’Ivoire with a tremendous global air traffic exposure. Cote d’Ivoire’s population and global air traffic exposure is more than the population of Guinea, Sierra Leone, and Liberia combined.
The international community writ large is already overwhelmed dealing with the three involved countries at-hand.
... Meanwhile, "scientific diplomacy" continues to inhibit progress in deciding which of the experimental vaccines to deploy. Ascel Bio assesses Geneva does not have adequate intelligence to determine the location of the leading edge of the expanding Ebola disaster and hence, appropriate knowledge of where to deploy vaccine- whenever they decide what vaccine to deploy.
There is a prevalent belief that plenty of time is available to debate the issues of scientific diplomacy (i.e. until January). The data suggests otherwise.